In Vitro and In Silico Evaluation of Bikaverin as a Potent Inhibitor of Human Protein Kinase CK2

In Vitro and In Silico Evaluation of Bikaverin as a Potent Inhibitor of Human Protein Kinase CK2

Protein kinase CK2 is an emerging target for therapeutic intervention in human diseases, particularly in cancer. Inhibitors of this enzyme are currently in clinical trials, indicating the druggability of human CK2. By virtual screening of the ZINC database, we found that the natural compound bikaver...

Full description

Bibliographic Details
Main Authors: Samer Haidar, Dagmar Aichele, Robin Birus, Janine Hielscher, Tuomo Laitinen, Antti Poso, Joachim Jose
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Molecules
Subjects:
antiproliferation
bikaverin
cell viability
molecular dynamics
permeability
Online Access:https://www.mdpi.com/1420-3049/24/7/1380

Internet

https://www.mdpi.com/1420-3049/24/7/1380

Similar Items